Literature DB >> 15744339

The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells.

M Uhrberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15744339     DOI： 10.1038/sj.leu.2403705

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  12 in total

1.  Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation.

Authors:  Costin Tomescu; Jihed Chehimi; Vernon C Maino; Luis J Montaner
Journal:  J Leukoc Biol       Date:  2009-02-23       Impact factor: 4.962

2.  Flow cytometric assay detecting cytotoxicity against human endogenous retrovirus antigens expressed on cultured multiple sclerosis cells.

Authors:  A Møller-Larsen; T Brudek; T Petersen; E L Petersen; M Aagaard; D T Hansen; T Christensen
Journal:  Clin Exp Immunol       Date:  2013-09       Impact factor: 4.330

3.  Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes.

Authors:  Maryam Hejazi; Angela R Manser; Julia Fröbel; Andrea Kündgen; Xiaoyi Zhao; Kathrin Schönberg; Ulrich Germing; Rainer Haas; Norbert Gattermann; Markus Uhrberg
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

4.  The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.

Authors:  Michael J Kelly-Sell; Youn H Kim; Suzanne Straus; Bernice Benoit; Cameron Harrison; Katherine Sutherland; Randall Armstrong; Wen-Kai Weng; Louise C Showe; Maria Wysocka; Alain H Rook
Journal:  Am J Hematol       Date:  2012-02-24       Impact factor: 10.047

5.  Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors.

Authors:  Sergey V Ryzhov; Michael W Pickup; Anna Chytil; Agnieszka E Gorska; Qinkun Zhang; Philip Owens; Igor Feoktistov; Harold L Moses; Sergey V Novitskiy
Journal:  J Immunol       Date:  2014-08-15       Impact factor: 5.422

6.  CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.

Authors:  Holbrook E Kohrt; Roch Houot; Matthew J Goldstein; Kipp Weiskopf; Ash A Alizadeh; Josh Brody; Antonia Müller; Russell Pachynski; Debra Czerwinski; Steven Coutre; Mark P Chao; Lieping Chen; Thomas F Tedder; Ronald Levy
Journal:  Blood       Date:  2010-12-30       Impact factor: 22.113

7.  Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection.

Authors:  Lei Zhao; Xiaoling Gao; Ying Peng; Antony G Joyee; Hong Bai; Shuhe Wang; Jie Yang; Weiming Zhao; Xi Yang
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

8.  Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.

Authors:  Holbrook E Kohrt; Ariane Thielens; Aurelien Marabelle; Idit Sagiv-Barfi; Caroline Sola; Fabien Chanuc; Nicolas Fuseri; Cécile Bonnafous; Debra Czerwinski; Amanda Rajapaksa; Erin Waller; Sophie Ugolini; Eric Vivier; François Romagné; Ronald Levy; Mathieu Bléry; Pascale André
Journal:  Blood       Date:  2013-12-10       Impact factor: 22.113

9.  NK cell isolation from liver biopsies: phenotypic and functional analysis of low cell numbers by flow cytometry.

Authors:  Ning Li; Gisella L Puga Yung; Amandine Pradier; Christian Toso; Emiliano Giostra; Isabelle Morard; Laurent Spahr; Jörg D Seebach
Journal:  Front Immunol       Date:  2013-03-11       Impact factor: 7.561

10.  Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells.

Authors:  Olivier Preynat-Seauve; Casimir de Rham; Diderik Tirefort; Sylvie Ferrari-Lacraz; Karl-Heinz Krause; Jean Villard
Journal:  J Cell Mol Med       Date:  2009-03-13       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.